XBiotech (XBIT) Return on Sales [ROS] (2020 - 2023)
XBiotech (XBIT) reported Return on Sales [ROS] of -2207.44% for Q3 2023, down 1827.14 percentage points from -380.30% a year earlier and down 1118.53 percentage points from the prior quarter.
Powered by 
Analysis
XBiotech (XBIT) Return on Sales [ROS] (2020 - 2023) Analysis & Trends
For FY2022, XBiotech posted Return on Sales [ROS] of -860.10%, down 723.74 percentage points from FY2021.
- By year, Return on Sales [ROS] came in at -136.36% in FY2021 (-94.82 pp) and -41.54% in FY2020.
- The Q3 2023 figure ranks as the lowest quarterly Return on Sales [ROS] in data going back to Q1 2020.
- Year over year, Return on Sales [ROS] gained in 1 of the last seven quarters, with an average year-over-year change of -554.77 percentage points.
- The high point for year-over-year Return on Sales [ROS] in five years was Q1 2023 (a gain of 658.22 percentage points); the low point was Q3 2023 (a drop of 1827.14 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 28.21% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 28.37% |
| 10 | XBiotech | 66.77 Mn | 66.77 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2023 | -2,207.44% |
| Jun 30, 2023 | -1,088.91% |
| Mar 31, 2023 | -910.78% |
| Sep 30, 2022 | -380.30% |
| Jun 30, 2022 | -790.46% |
| Mar 31, 2022 | -1,569.00% |
| Dec 31, 2021 | -159.84% |
| Sep 30, 2021 | -82.56% |
| Jun 30, 2021 | -234.36% |
| Mar 31, 2021 | -73.26% |
| Dec 31, 2020 | -93.41% |
| Sep 30, 2020 | -44.27% |
| Jun 30, 2020 | -42.03% |
| Mar 31, 2020 | -17.12% |
API Access
XBiotech Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=XBIT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "XBIT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=XBIT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();